|
 |
|
Italy Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests
The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
|
 |
|
$3900.00 |
| |
|
|
|
Japan Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests
The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
|
|
|
$3900.00 |
| |
|
|
|
Spain Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests
The report presents a detailed analysis of the Hepatitis diagnostics market in Spain. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
|
|
|
$3900.00 |
| |
|
|
|
UK Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests
The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
|
|
|
$3900.00 |
| |
|
|
|
US Hepatitis A, B, C, D, E Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Strategies, Country Market Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Tests
The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
|
|
|
$3900.00 |
| |
|
|
|
Emerging Infectious Disease Tests and Companies Developing New Technologies and Products
The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects for nearly 80 infectious diseases and viruses, including their scientific background, clinical significance and market needs for both current and emerging tests, vaccines, drugs and extensive listings of companies developing or marketing new technologies and products.Contains 650 pages and 47 tables
|
|
|
$3850.00 |
| |
|
|
|
Future US Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies
This report presents a comprehensive analysis of the US infectious disease testing market, including:
- Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Current scientific views on the� definition, epidemiology, and etiology of major infectious diseases and microorganisms....
|
|
|
$3850.00 |
| |
|
|
|
Global E. Coli Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
The report presents a detailed analysis of the E. Coli diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan....
|
|
|
$3850.00 |
| |
|
|
|
Global Papillomavirus Diagnostics Market: Growth Opportunities and Business Expansion Strategies
The report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.�Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. �The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
�����- Hospitals
�����- Commercial/Private Labs
�����- Physician Offices
�����- Public Health Labs
|
|
|
$3850.00 |
| |
|
|
|
Global Chlamydia Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
|
|
|
$3850.00 |
| |
|
|
|
Global Influenza Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
The report presents a detailed analysis of the Influenza diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Influenza definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
|
|
|
$3850.00 |
| |
|
|
|
US Enteric Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia....
|
|
|
$3850.00 |
| |
|
|
|
Innovative Adenovirus Diagnostic Technologies and Emerging Markets
The report contains 205 pages, 10 tables and presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Aeromonads Diagnostic Technologies and Emerging Markets
The report contains 200 pages, 7 tables and presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Campylobacter Diagnostic Technologies
And Emerging Markets
The report contains 230 pages, 14 tables and presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Campylobacter definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Chancroid Diagnostic Technologies and Emerging Markets
The report contains 220 pages, 8 tables and presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroid definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Chlamydia Diagnostic Technologies and Emerging Markets
The report contains 184 pages, 15 tables and presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
Innovative Clostridium Diagnostic Technologies and Emerging Markets
The report contains 225 pages, 8 tables and presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Clostridium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
|
|
|
$3850.00 |
| |
|
|
|
|